Q32 Bio (QTTB) FCF Margin Growth (1y) (2019 - 2023)
Q32 Bio (QTTB) FCF Margin Growth (1y) (2019 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,187.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Q32 Bio | 225.00 Mn | 174.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 418,039.00 |
| Sep 30, 2023 | 396,477.00 |
| Jun 30, 2023 | 364,163.00 |
| Mar 31, 2023 | 341,005.00 |
| Dec 31, 2022 | 69,626.00 |
| Sep 30, 2022 | -168,789.00 |
| Jun 30, 2022 | -283,915.00 |
| Mar 31, 2022 | -373,027.00 |
| Dec 31, 2021 | -296,174.00 |
| Sep 30, 2021 | 378,723.00 |
| Jun 30, 2021 | 342,474.00 |
| Mar 31, 2021 | 463,831.00 |
| Dec 31, 2020 | 730,706.00 |
| Sep 30, 2020 | -299,090.00 |
| Jun 30, 2020 | 377,978.00 |
| Mar 31, 2020 | 383,090.00 |
| Dec 31, 2019 | -646,529.00 |
| Sep 30, 2019 | -103,321.00 |
| Jun 30, 2019 | -736,580.00 |
| Mar 31, 2019 | -759,162.00 |